To exclude the possibility that EMT is dispensable for TBK1-induced CCA metastasis, we utilized a specific inhibitor targeting β-catenin, a key transcription factor involved in EMT, and concluded that EMT was required for TBK1-induced CCA metastasis. Here, TBK1 is linked to cholangiocarcinoma.